ODI-2001, a personalized combinatorial immunotherapy shows antitumoral activity across different syngeneic mice tumor models, including 4T1
Presentation Number: 805
Onsite Poster display dates:
- Immune Engineering Workshop Poster Session: Thursday, Nov. 7 from 3:10 – 5 p.m.
- Annual Meeting Poster Session: Friday, Nov. 8, 2024